Indianapolis and Tokyo (ots/PRNewswire) - In three early-phase trials,(1,2,3) an investigational platelet inhibitor, prasugrel (CS-747, LY640315), demonstrated significantly higher and more consistent inhibition of platelet aggregation (IPA) compared to both placebo and the current standard of care, clopidogrel ...
Lilongwe, Malawi (ots/PRNewswire) - The Abbott Fund, Baylor College of Medicine and the Government of Malawi have announced they will partner in the establishment of Malawi's first center dedicated to providing care and treatment for children with HIV/AIDS. Construction of the new clinic on the Kamuzu Central ...
Montreal (ots/PRNewswire) - Genizon BioSciences today announced the appointment of six key scientists within the company. Tim Keith, Ph.D., has joined the company as Vice President and Chief Scientific Officer. Dr. Keith, former Head of the Human Genetics Group at Genome Therapeutics (now Oscient Pharmaceuticals), has 18 years of experience in the biotechnology ...
Antwerp, Belgium (ots/PRNewswire) - - Results from RIO-Europe trial demonstrated that first-year improvements in cardiovascular risk factors are seen through two-year study period Luc Van Gaal, M.D. Principal Investigator RIO-Europe On behalf of the RIO Steering Committee The results of a two-year phase III study in 1,507 ...
Research Triangle Park, North Carolina (ots/PRNewswire) - - Fourth quarter 2004 net revenue of US$493.2 million, up 20% from same quarter in 2003 - Record backlog of US$2.6 billion as of Dec. 31, 2004 Quintiles Transnational Corp. today announced financial results for the year and quarter ended Dec. 31, 2004. Net revenue for 2004 was US$1.78 billion versus US$1.63 billion in 2003. Contribution ...
Basel, Switzerland (ots/PRNewswire) - - New Study Published Today Provides Further Evidence of the Benefit of Avastin(R) for Patients With Advanced Colorectal Cancer Data published for the first time today in the leading Journal of Clinical Oncology showed that the unique new cancer drug Avastin keeps ...
INGELHEIM, Germany,, February 28 (ots/PRNewswire) - - Tipranavir/r More Effective Than Lopinavir/r in Large-Scale Studies of Treatment-Experienced HIV-Positive Patients New data from multiple analyses presented last week at the 12th Conference on Retroviruses and Opportunistic Infections support the efficacy of the investigational non-peptidic protease ...
Madrid, Spain (ots/PRNewswire) - PharmaMar: - Yondelis: - Due to the good results presented at the ASCO (American Society of Clinical Oncology) meeting, the randomised pivotal trial on soft-tissue sarcoma was expanded so as to compile a dossier for a regulatory application. - Results presented on ovarian cancer formed the basis for preparing Phase III trials in combination with Doxil. - The FDA (Food and Drug Administration) granted orphan ...
Santa Clara, California (ots/PRNewswire) - Align Technology, Inc. (Nasdaq: ALGN), the inventor of Invisalign(R), a proprietary method of straightening teeth without wires and brackets, today announced that the San Francisco County Superior Court has granted a Temporary Restraining Order ("TRO") against defendants ...
Madrid, Spain (ots/PRNewswire) - PharmaMar announces that its second most advanced marine-derived anti-tumour agent, Aplidin(R), has commenced Phase II clinical trials in both prostate and bladder cancers. Phase II trial in Prostate Cancer This is the first trial of Aplidin in solid tumours to be carried out in the United States (US). This study will focus ...
Copenhagen, Denmark (ots/PRNewswire) - Gastrotech Pharma A/S announced today that Dr. Hans T. Schambye has been appointed as its Chief Executive Officer. He replaces Professor Claes Post who will continue to serve the company as a member of Gastrotech's Board of Directors and Senior Vice President. Dr. Post will focus entirely on identification and evaluation of ...
Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. announced today that the original target of 400 subjects for its Canadian Phase III psoriasis trial for its lead immunosuppressive compound, ISA247 has been reached. Due to the enthusiasm of our investigators and the willingness of patients to participate in the trial, the Company will allow approximately 80 ...
Bothell, Washington and Indianapolis, Indiana (ots/PRNewswire) - Lilly ICOS LLC (NYSE: LLY and Nasdaq: ICOS), marketer of Cialis(R) (tadalafil), a PDE5 inhibitor indicated for the treatment of erectile dysfunction (ED), is pleased with the European Patent Office's (EPO) final decision to affirm its earlier ...
Laval, Canada (ots/PRNewswire) - - Danish Contract Research Organization Will Help Double LAB Research's Revenues LAB International Inc. (TSX: LAB, Frankfurt: LD9.F, XETRA: LD9.DE), an integrated drug development company with a focus on inhalation delivery, today announced it has acquired all shares of Scantox, Biologisk Laboratorium A/S (Denmark), the leading Scandinavian, non- clinical contract research organization, for a total cash consideration of 28 million ...
San Diego, California and Reykjavik, Iceland (ots/PRNewswire) - - Continues Research to Validate Significance of SEQUENOM's Portfolio of Breast Cancer Genetic Discoveries SEQUENOM, Inc. (NASDAQ: SQNM) and Iceland Genomics Corporation (Iceland Genomics), a privately-held company, entered into a ...
Santa Clara, California (ots/PRNewswire) - Align Technology, Inc. (Nasdaq: ALGN), the inventor of Invisalign(R), a proprietary method of straightening teeth without wires and brackets, today filed a multi-claim lawsuit in San Francisco County Superior Court against defendants OrthoClear, Inc., OrthoClear Holdings, Inc., Muhammad Ziaullah Chishti, Bao Tran, Peter Riepenhausen, Joe Breeland, Jeff Tunnell, Christopher Kawaja, and Charles Wen. Among other things, the lawsuit ...
Carlsbad, California (ots/PRNewswire) - - Medex Commits More Than US$1.4 Million in Medical Product Contributions Medex, a global manufacturer and marketer of medical devices, announced today that it has authorized medical product donations of more than US$1.4 million to assist with relief efforts throughout tsunami-affected countries and other regions requiring assistance. Working through AmeriCares, ...
Basel, Switzerland (ots/PRNewswire) - - Study adds to the body of evidence showing the benefits of Avastin with different colorectal cancer treatment regimens A new study, presented for the first time today, shows Avastin(R) (bevacizumab, rhuMAb-VEGF) significantly increases survival in patients with ...
Basel, Switzerland (ots/PRNewswire) - - New data shows significant improvement in overall survival when Tarceva is added to chemotherapy New data, presented for the first time today, have shown that adding Tarceva (erlotinib) to chemotherapy improves survival in patients with locally advanced or metastatic pancreatic cancer(1). This is the second cancer type ...
St. Gallen, Switzerland (ots/PRNewswire) - In postmenopausal women with early breast cancer, letrozole offers better post-surgery protection against breast cancer recurrence than does tamoxifen, the current standard of care, according to data presented today at the Primary Therapy of Early Breast Cancer 9th ...
St. Gallen, Switzerland (ots/PRNewswire) - - Promising News for Breast Cancer Patients - Web Cast Briefing Available at http://www.ibcsg.org/index.shtm WHAT: BIG 1-98: First results and implications. A landmark, independent study found that letrozole, a leading aromatase inhibitor also known as Femara, demonstrated ...
Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. announced today that the Company has completed recruitment for its Canadian Phase III psoriasis trial for its lead immunosuppressive compound, ISA247. Of the 400 subjects enrolled in the trial, 207 subjects have commenced treatment. The Company received a "No Objection Letter" from Health Canada on December 1, 2004 and commenced the trial on December 2, 2004. ...
Bothell, Washington and Indianapolis, Indiana (ots/PRNewswire) - - 2004 Worldwide Sales of Cialis Top US$550 Million - Lilly ICOS LLC (Lilly ICOS) (NYSE: LLY and Nasdaq: ICOS) is releasing its financial results for the fourth quarter and year ended December 31, 2004. Largely driven by the first year of sales in the United States, worldwide sales of Cialis(R) (tadalafil) surged 172% in 2004, to US$552 million, ...
Rochester, New York (ots/PRNewswire) - - Acquisition Broadens Kodak's CR Portfolio; Provides Foundation for Continued Growth - With Photo Eastman Kodak Company today announced it has entered into an agreement to acquire OREX Computed Radiography Ltd., a leading provider of compact, robust computed radiography systems that enable medical practitioners to ...
Madrid, Spain (ots/PRNewswire) - PharmaMar announced today that Zalypsis(R) (PM00104/50), its fifth new marine derived compound, has begun Phase I clinical trials, already in patients, for the treatment of solid tumours. Zalypsis is a novel chemical entity related to the marine natural compounds Jorumycin and the family of Renieramycins, obtained from molluscs ...
Paris (ots/PRNewswire) - - Menactra Vaccine is Safe and Effective in Preventing Potentially Deadly Meningococcal Disease Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has licensed Menactra(TM) (Meningococcal [Groups A, ...
Basel, Switzerland (ots/PRNewswire) - - First Treatment of its Kind With Proven Survival Benefit for Patients With Advanced Colorectal Cancer Roche today announced that the European Commission has approved Avastin (bevacizumab, rhuMAb-VEGF), the new innovative anti-angiogenesis drug, for the treatment of patients with previously untreated metastatic colorectal cancer. Roche will now make Avastin available ...
Phuket, Thailand (ots/PRNewswire) - The Thai government is in the process of establishing an international standard post mortem and ante-mortem identification centre in Phuket as the processing of victims of the tsunami that hit Thailand gets underway. There are now disaster victim identification (DVI) teams from 19 countries in Thailand working under the command of General Nopadol of the Royal Thai Police, the ...
Zurich, Switzerland (ots/PRNewswire) - Baxter Healthcare S.A. announced today that the European Commission has granted expanded approval of ADVATE(R) (Octocog Alfa Recombinant Coagulation Factor VIII), for use in children with haemophilia A under six years of age. This expanded approval was granted on the ...
Abbott Park, Illinois (ots/PRNewswire) - - HUMIRA Data Shows Slowed Joint Damage in Pivotal Study Abbott (NYSE: ABT) announced it has simultaneously submitted a Type II Variation to the European Medicines Agency (EMEA) and a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug ...